Showing results (2231-2240 of 2,811) with videos related to
Sort By:
Pageof 282
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Characterizing the clinical benefit of ipilimumab in patients who progressed on high-dose IL-2Richard W Joseph, Jeanette E Eckel-Passow, Ruchi Sharma, et al.Pediatrics|February 3, 2006
A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and VarivaxKeith S Reisinger, Michelle L Hoffman Brown, Jin Xu, et al.Frontiers in Pharmacology|June 20, 2022
Models and Techniques to Study Aortic Valve Calcification in Vitro, ex Vivo and in Vivo. An OverviewMaria Bogdanova, Arsenii Zabirnyk, Anna Malashicheva, et al.The Journal of Infectious Diseases|September 2, 2015
Uropathogenic Escherichia coli Engages CD14-Dependent Signaling to Enable Bladder-Macrophage-Dependent Control of Acute Urinary Tract InfectionAlison J Carey, Matthew J Sullivan, Benjamin L Duell, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|April 6, 2013
Chemerin connects fat to arterial contractionStephanie W Watts, Anne M Dorrance, Mark E Penfold, et al.American Journal of Physical Medicine & Rehabilitation|January 5, 2008
The physical therapy clinical research network (PTClinResNet): methods, efficacy, and benefits of a rehabilitation research networkCarolee Winstein, Patricia Pate, Tingting Ge, et al.The Oncologist|June 14, 2025
First-in-human phase I/II, open-label study of mRNA-2416 alone or combined with durvalumab in patients with advanced solid tumors and ovarian cancerRyan J Sullivan, Oladapo O Yeku, Deanna Teoh, et al.Journal of the American Association for Laboratory Animal Science : JAALAS|December 20, 2013
Survey of laboratory animal technicians in the United States for Coxiella burnetii antibodies and exploration of risk factors for exposureEllen A Spotts Whitney, Robert F Massung, Gilbert J Kersh, et al.Cancer|December 7, 2018
Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who previously have received programmed cell death protein 1-based therapyKarim R Saab, Meghan J Mooradian, Daniel Y Wang, et al.Nature Medicine|August 22, 2018
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanomaNoam Auslander, Gao Zhang, Joo Sang Lee, et al.Pageof 282